Brainstorm Cell Therapeutics  logo
Brainstorm Cell Therapeutics BCLI
$ 1.11 -5.34%

Quarterly report 2024-Q2
added 08-14-2024

report update icon

Brainstorm Cell Therapeutics Depreciation & Amortization 2011-2024 | BCLI

Annual Depreciation & Amortization Brainstorm Cell Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
265 K 285 K 260 K 219 K 164 K 110 K 85 K 77 K 87 K 106 K 97 K 157 K 153 K

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
285 K 77 K 159 K

Quarterly Depreciation & Amortization Brainstorm Cell Therapeutics

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
64 K 64 K - 65 K 67 K 67 K - 70 K 71 K 74 K - 67 K 62 K 61 K - 56 K 50 K 49 K - 37 K 33 K 44 K - 33 K 31 K 25 K - 23 K 18 K 16 K - 17 K 22 K 16 K - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
74 K 16 K 46.2 K